MRAD-P1

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMRAD-P1
Drug Alias Namevoltage-gated potassium channel modulator (Wuhan More Biotechnology)Kv1.3 modulator (Wuhan More Biotechnology)MRAD-P1
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVoltage-gated potassium channel subunit Kv1.3 modulators
TargetsVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesWuhan More Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWuhan More Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A